Drospirenonum + Ethinylestradiolum
Lesine Ethinylestradiol/Drospirenone 0.03 mg/3 mg Theramexare different trade names for the same drug.
Lesine is a contraceptive pill and is used to prevent pregnancy.
Each tablet contains a small amount of two different female hormones, namely drospirenone and ethinylestradiol.
Contraceptive pills containing two hormones are called "combined" pills.
Before starting to take Lesine, you should read the information about blood clots (thrombosis) in section 2. It is especially important to read about the symptoms of blood clots (see section 2 "Blood clots (thrombosis)").
Before you can start taking Lesine, your doctor will ask you a few questions about your health and the health of your close relatives. Your doctor will also measure your blood pressure and, in individual cases, may also perform certain other tests.
This leaflet describes several situations in which you should stop taking Lesine, or in which the effectiveness of Lesine may be reduced. In such situations, you should either not have sexual intercourse or use additional non-hormonal contraceptive methods, such as condoms or other mechanical methods. You should not use the calendar method or the temperature measurement method. These methods may be unreliable because Lesine modifies the monthly changes in body temperature and cervical mucus.
You should not take Lesine if you have any of the following conditions. If you have any of the following conditions, you should inform your doctor. Your doctor will discuss with you which other contraceptive method will be more suitable for you.
Additional information for special populations
Children and adolescents
Lesine is not intended for use in girls who have not yet started their menstrual cycle.
Elderly women
Lesine is not intended for use after menopause.
Women with liver disease
You should not take Lesine if you have liver disease. See also sections "When not to take Lesine" and "Warnings and precautions".
Women with kidney disease
You should not take Lesine if you have kidney failure or acute kidney failure. See also sections "When not to take Lesine" and "Warnings and precautions".
Before starting to take Lesine, you should discuss it with your doctor or pharmacist.
When should you contact your doctor?
You should see your doctor immediately
In order to describe the symptoms of the serious side effects mentioned, see "How to recognize a blood clot".
In certain situations, you should be particularly careful when taking Lesine or any other combined hormonal contraceptive, and you may also need to be regularly examined by your doctor.
If these symptoms occur or worsen while taking Lesine, you should also tell your doctor:
Taking combined hormonal contraceptives, such as Lesine, is associated with an increased risk of blood clots compared to not taking them. In rare cases, a blood clot can block a blood vessel and cause serious complications.
Blood clots can occur
Not everyone who has a blood clot will recover completely. In rare cases, the effects of a blood clot can be long-term or, very rarely, fatal.
You should see your doctor immediately if you notice any of the following symptoms.
What disease is the patient likely to have?
| |
Symptoms usually occur in one eye:
| Retinal vein thrombosis (blood clot in the eye) |
| Myocardial infarction |
| Stroke |
| Blood clots blocking other blood vessels |
The risk of forming a blood clot in a vein is highest during the first year of taking combined hormonal contraceptives for the first time. The risk may also be higher when resuming combined hormonal contraceptives (the same or a different product) after a break of 4 weeks or more.
After the first year, the risk decreases, but it is always higher compared to not taking combined hormonal contraceptives.
If you stop taking Lesine, the risk of blood clots returns to normal within a few weeks.
The risk depends on the natural risk of venous thromboembolism and the type of combined hormonal contraceptive used.
The overall risk of blood clots in the legs or lungs associated with taking Lesine is small.
Risk of blood clots in a year | |
Women who do not take combined hormonal pills/patches/systems and are not pregnant | About 2 out of 10,000 women |
Women taking combined hormonal contraceptive pills containing levonorgestrel, norethisterone, or norgestimate | About 5-7 out of 10,000 women |
Women taking Lesine | About 9-12 out of 10,000 women |
The risk of blood clots associated with taking Lesine is small, but some factors can increase this risk. The risk is higher:
The risk of blood clots increases with the number of risk factors present in the patient.
Long-haul flights (>4 hours) may temporarily increase the risk of blood clots, especially if you have another risk factor.
It is important to tell your doctor if any of these risk factors apply to you, even if you are not sure. Your doctor may decide to stop taking Lesine.
You should inform your doctor if any of the above conditions change while taking Lesine, e.g., if someone in your close family is diagnosed with a blood clot without a known cause or if you gain weight significantly.
Similarly to blood clots in veins, blood clots in arteries can cause serious consequences, such as a heart attack or stroke.
It is important to note that the risk of a heart attack or stroke associated with taking Lesine is very small, but it may increase:
If you have more than one of these conditions or if any of them are particularly severe, the risk of a blood clot may be even higher.
You should inform your doctor if any of the above conditions change while taking Lesine, e.g., if you start smoking, if someone in your close family is diagnosed with a blood clot without a known cause, or if you gain weight significantly.
Women taking combined contraceptives have a slightly higher risk of breast cancer, but it is not known if this is caused by the contraceptive. For example, it may be that more tumors are detected in women taking combined contraceptives because they are examined by doctors more often.
The frequency of breast tumors decreases gradually after stopping combined hormonal contraceptives.
It is important to examine your breasts regularly and contact your doctor if you feel any lump.
Women taking combined contraceptives have also been reported to have, in rare cases, benign liver tumors, and in even rarer cases, malignant liver tumors. If you experience severe abdominal pain, you should contact your doctor.
During the first few months of taking Lesine, you may experience irregular bleeding (bleeding outside of the weekly break). If such bleeding continues for longer than a few months or starts after a few months, your doctor should investigate the cause.
If you have taken all the tablets as directed, have not vomited, or have not had severe diarrhea, and have not taken any other medicines, it is very unlikely that you are pregnant.
If the expected bleeding does not occur for two consecutive weeks, it may mean that you are pregnant. You should contact your doctor immediately. Do not start the next blister pack until you are sure you are not pregnant.
Some women taking hormonal contraceptives, including Lesine, have reported depression or low mood. Depression can be severe and sometimes lead to suicidal thoughts.
If you experience mood changes or symptoms of depression, you should contact your doctor as soon as possible for further medical advice.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
You should also tell any other doctor or dentist prescribing another medicine (or pharmacist) that you are taking Lesine. They may tell you if you need to use additional contraceptive methods (such as condoms) and for how long or if you need to adjust your other medicines.
Certain medicines may affect the levels of Lesine in your blood and may make it less effective in preventing pregnancy or may cause irregular bleeding. These include:
Lesine may affect the action of other medicines, such as:
Before taking any medicine, you should consult your doctor or pharmacist.
You should not take Lesine if you have hepatitis C and are taking medicines containing ombitasvir/paritaprevir/ritonavir, dasabuvir, glecaprevir/pibrentaswir, or sofosbuvir/velpatasvir/voxilaprevir, as this may cause increased liver enzyme levels in the blood (increased ALT activity).
Your doctor will prescribe a different contraceptive method before starting treatment with these medicines.
Lesine can be taken again about 2 weeks after finishing this treatment. See section "When not to take Lesine".
Lesine can be taken with or without food, if necessary with a small amount of water.
If a blood test is necessary, you should tell your doctor or laboratory staff that you are taking a contraceptive, as oral contraceptives may affect the results of some tests.
Pregnancy
Lesine should not be taken during pregnancy. If you become pregnant while taking Lesine, you should stop taking it immediately and contact your doctor.
If you want to become pregnant, you can stop taking Lesine at any time (see also "Stopping Lesine").
Before taking any medicine, you should consult your doctor or pharmacist.
Breastfeeding
Lesine is not usually recommended during breastfeeding. If you want to use a contraceptive method while breastfeeding, you should contact your doctor.
Before taking any medicine, you should consult your doctor or pharmacist.
There is no information to suggest that taking Lesine affects the ability to drive or use machines.
If you have been diagnosed with an intolerance to some sugars, you should contact your doctor before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per dose, which means it is essentially "sodium-free".
This medicine should always be taken as directed by your doctor or pharmacist. If you are unsure, you should contact your doctor or pharmacist.
You should take one Lesine tablet every day, if necessary with a small amount of water.
The blister pack contains 21 tablets. The day of the week is printed next to each tablet. If, for example, you start taking the tablets on a Wednesday, you should take the tablet with "Wed" printed next to it (see "Translation of day symbols on the packaging" at the end of the leaflet).
You should move in the direction of the arrow on the blister pack until all 21 tablets have been taken.
Then, you should not take any tablets for 7 days. During these 7 days (also called the "tablet-free week"), you should experience bleeding. This is called "withdrawal bleeding", which usually starts on the 2nd or 3rd day of the tablet-free week.
On the 8th day after taking the last Lesine tablet (i.e., after the 7-day break), you should start a new blister pack, regardless of whether the bleeding has stopped or not. This means you should start each new blister pack on the same day of the week, and the withdrawal bleeding should occur on the same days every month.
If you take Lesine in this way, you are protected from pregnancy during the 7 days when you are not taking tablets.
If you have had sexual intercourse after childbirth, before (re)starting Lesine, you should first make sure you are not pregnant or wait for your first menstrual period.
If you are unsure when to start taking Lesine, you should consult your doctor.
There are no reports of serious, harmful effects from taking too many Lesine tablets.
If you take several tablets at once, you may experience nausea and vomiting or vaginal bleeding. This type of bleeding can occur even in girls who have not yet started their menstrual cycle, but have taken the medicine by mistake.
If you take too many Lesine tablets or if a child has taken them, you should consult your doctor or pharmacist.
The risk of reduced protection from pregnancy is highest if you forget tablets at the beginning or end of the blister pack. Therefore, you should follow the rules below (see also the diagram below):
You will probably experience bleeding at the end of the second blister pack, but you may also experience spotting or irregular bleeding while taking tablets from the second blister pack.
If you follow one of these two recommendations, your protection from pregnancy will be maintained.
If you vomit within 3-4 hours of taking a tablet or have severe diarrhea, there is a risk that the active substances in the tablet have not been fully absorbed into your body.
The situation is similar to forgetting a tablet. After vomiting or diarrhea, you should take another tablet from a spare blister pack as soon as possible. If possible, you should take it within 12 hoursof the normal time you take your tablet. If this is not possible or more than 12 hours have passed, you should follow the instructions in the section "Forgetting to take Lesine".
Although it is not recommended, you can delay your period by going directly to a new Lesine blister pack, skipping the tablet-free period, until the end of the pack. You may experience spotting or irregular bleeding while taking tablets from the second blister pack.
After the usual 7-day tablet-free period, you should start taking tablets from the next blister pack.
You can ask your doctor for advice before deciding to delay your period.
If you take the tablets as directed, you will experience bleeding during the tablet-free week. If you want to change this day, you can do so by shortening (but never lengthening - maximum 7 days!) the tablet-free period. For example, if your tablet-free period starts on a Friday and you want to change it to a Tuesday (3 days earlier), you should start a new blister pack 3 days earlier than usual. If the tablet-free period is significantly shortened (e.g., to 3 days or less), you may experience bleeding during those days. As a result, you may experience spotting or irregular bleeding.
If you are unsure what to do, you should contact your doctor.
You can stop taking Lesine at any time. If you do not want to become pregnant, you should consult your doctor about other effective methods of birth control. If you want to become pregnant, you should stop taking Lesine and wait for your menstrual period before trying to become pregnant. This way, it is easier to calculate the expected date of delivery.
If you have any further doubts about taking this medicine, you should contact your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any side effects, especially severe or persistent ones, or changes in your health that you think may be related to the use of Lesine, you should consult your doctor.
In all women using combined hormonal contraceptives, there is an increased risk of blood clots in the veins (venous thromboembolism) or blood clots in the arteries (arterial thromboembolism). For detailed information on the different risk factors associated with the use of combined hormonal contraceptives, please refer to section 2 "Important information before taking Lesine".
The following side effects have been associated with the use of Lesine.
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1000 people):
The likelihood of blood clots may be higher if you have any other risk factors that increase this risk (see section 2 for more information on risk factors for blood clots and symptoms of blood clots).
If you experience any side effects, including those not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C,
02-222 Warsaw,
Phone: +48 22 49 21 301,
Fax: +48 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
There are no special storage instructions.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of the medicine are ethinylestradiol and drospirenone.
Each coated tablet contains 0.03 mg of ethinylestradiol and 3 mg of drospirenone.
The other ingredients are:
Tablet core: lactose monohydrate, corn starch, pregelatinized starch, cornstarch, crospovidone, povidone K 30, polysorbate 80, magnesium stearate.
Tablet coating: Opadry II Yellow (partially hydrolyzed polyvinyl alcohol, titanium dioxide (E 171), macrogol 3350, talc, yellow iron oxide (E 172)).
Yellow, round, coated tablets.
Lesine is available in boxes of 1 or 3 blisters, each containing 21 tablets. The packaging includes a cardboard sachet in which the blister should be placed.
For more detailed information, please contact the marketing authorization holder or parallel importer.
Theramex Ireland Limited
3 Floor, Kilmore House,
Park Lane, Spencer Dock,
Dublin 1
D01 YE64
Ireland
Laboratorios León Farma, S.A.
Pol. Ind. Navatejera
C/La Vallina s/n
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Netherlands export license number: RVG 107290
maa
[Information about the trademark]
Member State | Medicinal Product Name |
Norway: | Dretine 0,03 mg/3 mg tablets, film-coated |
Austria: | Dretine 0,03 mg/3 mg 21 film-coated tablets |
Czech Republic: | Softine 0,03 mg/3 mg coated tablets |
Denmark: | Dretine film-coated tablets |
Spain: | Dretine 0.03 mg/3 mg film-coated tablets |
Finland: | Dretine 0,03 mg/3 mg tablets, film-coated |
Hungary: | Corenelle 0.03 mg/3 mg film-coated tablets |
Ireland: | Dretine 0.03 mg/3 mg film-coated tablets |
Poland: | Lesine |
Slovakia: | Softine 0,03mg/3mg film-coated tablets |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.